Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
British Journal of Haematology|January 22, 2016
Chimeric Antigen Receptor (CAR) therapy for multiple myelomaDjordje Atanackovic, Sabarinath V Radhakrishnan, Neelam Bhardwaj, et al.Cell Transplantation|October 18, 2019
A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple MyelomaSabarinath V Radhakrishnan, Michael Boyer, Catherine M Sherwin, et al.Nature Communications|February 9, 2020
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricideSabarinath V Radhakrishnan, Tim Luetkens, Sandra D Scherer, et al.Biorxiv : the Preprint Server for Biology|February 19, 2024
Restricting CAR T Cell Trafficking Expands Targetable Antigen SpaceErin A Morales, Kenneth A Dietze, Jillian M Baker, et al.Signal Transduction and Targeted Therapy|April 22, 2026
Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell functionKenneth A Dietze, Kiet Nguyen, Aashli Pathni, et al.Science Translational Medicine|July 19, 2023
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicityErica R Vander Mause, Jillian M Baker, Kenneth A Dietze, et al.Nature Medicine|May 20, 2014
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damageLukas Schwab, Luise Goroncy, Senthilnathan Palaniyandi, et al.Pageof 1